跳至主要内容
临床试验/NCT01845207
NCT01845207已完成不适用

Frailty Assessment Before Cardiac Surgery & Transcatheter Interventions

Jewish General Hospital14 个研究点 分布在 3 个国家目标入组 800 人开始时间: 2012年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
800
试验地点
14
主要终点
Post-procedural mortality or major morbidity

研究概览

简要总结

Frailty is a state of decreased physiologic reserves and vulnerability to stressors. Several tools exist to measure frailty, some based on physical tests and others on questionnaires, yet there is no agreement on which tool to recommend. This multi-center prospective cohort study is aimed at comparing various frailty assessment tools to determine which best predicts death or major complications after cardiac surgery or transcatheter intervention. The population of interest is elderly patients with severe aortic stenosis undergoing surgical or transcatheter aortic valve replacement. The frailty assessment tools under investigation include composite frailty scales, physical performance tests, muscle mass, and biomarker expression. The overall objective is to improve our ability to predict risk by measuring frailty using the optimal tool in elderly cardiovascular patients.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
70 Years 至 —(Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥70 years (a site-specific substudy at the JGH will enroll ages ≥21 years)
  • Referred for surgical or transcatheter AVR (with or without concomitant revascularization)
  • Signed informed consent

排除标准

  • Emergency surgery
  • Clinical instability: decompensated heart failure, active ischemia, unstable vital signs
  • Severe neuropsychiatric impairment
  • Not English or French speaking
  • Replacement of >1 valve or aortic surgery

结局指标

主要结局

Post-procedural mortality or major morbidity

时间窗: 30 days

Mortality is defined as death from any cause. Major morbidity is defined as an aggregate of the Society of Thoracic Surgeons (STS) and Valve Academic Research Consortium (VARC) composite endpoints. Additionally, the individual components of this composite endpoint will be examined.

次要结局

  • All-cause mortality(6-12 months)
  • Length of stay(30 days)
  • Functional status(6-12 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jonathan Afilalo

MD MSc FACC FRCPC

Jewish General Hospital

研究点 (14)

Loading locations...

相似试验